Use of thrombolytic agents in the treatment of acute pulmonary thromboembolism: things are not as simple as you might think

Miranda, Carlos Henrique; Fernandes, Caio Julio Cesar dos Santos; Jardim, Carlos Vianna Poyares; Alves Jr, José Leonidas; Oleas, Francisca Alexandra Gavilanes; Morinaga, Luciana Tamie Kato; Souza, Rogério de.
J. bras. pneumol ; 45(1): e20180297, 2019.
Artículo en Inglés | LILACS | ID: biblio-984622

Documentos relacionados

  1. [Clinical implications of thrombolytic therapy for patients with acute intermediate-high risk pulmonary embolism in Tibet plateau, China].
  2. In intermediate- or high-risk PE, catheter-directed thrombolysis is linked to reduced mortality vs. systemic thrombolysis or anticoagulation.
  3. A case study on thrombolytic treatment of acute aortic saddle embolism using bilateral femoral arterial puncture catheter.
  4. Factors influencing recanalization of thrombotic venous occlusions.
  5. Efficacy of ultrasound assisted catheter-directed thrombolysis compared to catheter-directed thrombolysis in vitro.
  6. Intravenous Thrombolytic Therapy Remains the Basis and Mainstay of Revascularizing Therapy!
  7. Letter by Cai et al Regarding Article, "One-Year Home-Time and Mortality After Thrombolysis Compared With Nontreated Patients in a Propensity-Matched Analysis".
  8. Response by Castonguay et al to Letter Regarding Article "Intraarterial Thrombolysis as Rescue Therapy for Large Vessel Occlusions".
  9. Trends and outcomes of lytic-based therapies for high-risk pulmonary embolism: A nationwide analysis.
  10. Advances in Nano-Functional Materials in Targeted Thrombolytic Drug Delivery.